MIR22HG and osteosarcoma: In conclusion, the discoveries in this study unveil the participation of lncRNA MIR22HG in osteosarcoma, and demonstrate that overexpressed MIR22HG represses the viability and proliferation but promotes the apoptosis of osteosarcoma cells via the miR-629-5p/TET3 axis.